This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Niki Tomas Loges: Innovator in Ciliopathy Treatment
Introduction
Niki Tomas Loges is a prominent inventor based in Rheine, Germany. She is currently associated with Ethris GmbH, where she focuses on groundbreaking research in the field of pharmaceutical compositions. Her work aims to address complex medical conditions, particularly ciliopathies, which are disorders caused by defects in cilia.
Latest Patent Applications
Niki Tomas Loges has made significant contributions through her patent application titled "Treatment of Ciliopathies." This application presents a pharmaceutical composition that includes a polyribonucleotide designed to treat ciliopathies in affected subjects. The polyribonucleotide encodes a functional version of a protein whose defect is linked to the ciliopathy. The application emphasizes the administration of this composition to the respiratory system, particularly when the subject exhibits respiratory inflammation. Additionally, the application outlines a method for analyzing the effects of the polyribonucleotide on ciliogenesis, highlighting its role in the development of cilia.
Conclusion
Niki Tomas Loges is making strides in the treatment of ciliopathies through her innovative research and patent applications. Her work at Ethris GmbH showcases her commitment to advancing medical science and improving patient outcomes.